Covaxin
Corbevax approved as precaution dose for adults vaccinated with Covaxin, Covishield
This is for the first time that a booster dose that is different from the one used for primary vaccination against Covid has been allowed
DCGI grants EUA to Corbevax for those aged 5-12, Covaxin for 6-12 age group
Authorisation given to Cadila for its ZyCoV-D for an additional dose of 3mg with a two-jab inoculation schedule for those aged above 12
WHO suspends Covaxin supply to UN agencies
The suspension is in response to the outcomes of its post Emergency Use Authorisation inspection held between March 14-22, WHO said
Two COVID vaccines may cost Rs. 275 after market nod
The National Pharmaceutical Pricing Authority (NPPA) has already been directed to start working towards capping the price
SEC approval for Bharat Biotech's COVID booster intranasal vaccine phase 3 trials
The SEC has asked the Hyderabad-based vaccine manufacturer to submit its revised protocol for trials
COVID-19: India supplies 5 lakh more Covaxin doses to Afghanistan
The last batch of humanitarian assistance consisting of 5,00,000 doses of Covaxin was supplied to Afghanistan on January 1
Shobhaa De | Are Padma awards for the ‘common’ man? Not really!
For the very first time in the history of the Padma awards, I felt elated after scrutinising the eclectic list of awardees
UK to add Covaxin to approved vaccine list from November 22
The move follows the World Health Organisation's Emergency Use Listing for Covaxin, which is the second most used formulation in India
Bharat Biotech's partner seeks Covaxin approval in US for children below 18 years
The World Health Organisation on Wednesday granted approval for Emergency Use Listing Covaxin
WHO grants emergency use licence to Bharat Biotech's Covaxin
CDSCO has approved the extension of shelf life of Covaxin up to 12 months from the date of manufacture